|
|
|
|
|
by beerandt
1625 days ago
|
|
>Vaccines still lower disease severity. Not for kids under 5. That's why it's not approved. >And of course you don't want to infect your child with a disease Breakthrough cases are so common now that the media refuses to use the term anymore. That (lack-of) "preventing-infection" efficacy is baked into the <5 study that showed no benefit. >that has long term consequences which we are still learning about. Why is this a valid concern, but potential long-term effects of the vaccines aren't? Especially the known risk of inflammation in still-growing bodies and especially in developing hearts. |
|
Wrong. Per the Pfizer press release [0], the immunogenicity analysis of the trial failed in children ages 2 to 4, but succeeded in children ages six months to two years. Given the small dose (3ug) in that study cohort, there was probably not enough rna in the vaccine for the 2-4 age group to show any effect.
>Why is this a valid concern, but potential long-term effects of the vaccines aren't? Especially the known risk of inflammation in still-growing bodies and especially in developing hearts.
The risk of developing myocarditis from the vaccine is about 100-150 in 5 million [1]. The risk of developing myocarditis from COVID-19 is about 150 in 100,000 [2]. I know I'm picking the vaccine for my child.
[0] https://www.pfizer.com/news/press-release/press-release-deta... [1] https://www.nature.com/articles/d41586-021-02740-y [2] https://www.cdc.gov/mmwr/volumes/70/wr/mm7035e5.htm
edited for typos.